NIH awards OHSU nearly $4 million to test genome editing technologies

By Tracy Brawley October 18, 2018 Portland, Oregon

Downloads

Carrie Hanna, Ph.D., director of the assisted reproductive technologies core laboratory at ONPRC, in the laboratory, Oct. 10, 2018. (OHSU/Kristyna Wentz-Graff)

Jon Hennebold, Ph.D. (OHSU)

Genome editing

A small laser is used to cut away about 15 cells from the rhesus macaque blastocyst stage embryo (right) to determine if the embryo genome was properly edited. If the genome sequencing results are favorable, the embryo can them be transferred into a surrogate. (OHSU)

Genome editing

(Left to right) Jon Hennebold, Ph.D., Carrie Hanna, Ph.D., Benjamin Burwitz, Ph.D. and Benjamin Bimber, Ph.D., involved on a project aimed at accelerating the translation of genome editing techniques into a clinical application. (OHSU/Kristyna Wentz-Graff)